| | | | |
CUSIP No. M9607U115 | | 13G | | 5 |
This Statement represents Amendment No. 1 to the Schedule 13G (the “Original Schedule 13G”) originally filed with the Securities and Exchange Commission (the “SEC”) by the Reporting Persons on February 11, 2022. All capitalized terms not otherwise defined herein have the meanings set forth in the Original Schedule 13G.
Item 1(a). Name of Issuer:
Valens Semiconductor Ltd.
Item 1(b). Address of Issuer’s Principal Executive Officers:
8 Hanagar St. POB 7152
Hod Hasharon 4501309
Israel
Item 2(a). Name of Person(s) Filing:
Linse Capital VAL, LLC (“Linse VAL”)
Linse Capital LLC (“Linse Capital”)
Michael Linse (“Linse”)
Item 2(b). Address of Principal Business Office:
Linse Capital LLC
53 Calle Palmeras, Suite 601
San Juan, Puerto Rico 00901
Item 2©. Citizenship:
| | |
Linse VAL Linse Capital | | Delaware, United States of America Delaware, United States of America |
Linse | | United States of America |
Item 2(d). Title of Class of Securities:
Ordinary Shares, No Par Value
Item 2(e). CUSIP Number:
M9607U115
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
Not applicable.
Item 4(a). Amount Beneficially Owned:
Item 4(b). Percent of Class:
Item 4(c). Number of shares as to which such persons have:
The following information with respect to the beneficial ownership of Ordinary Shares by the Reporting Persons filing this statement on Schedule 13G is provided as of November 19, 2024: